Main content

New antiviral Covid pill

A new Covid pill may cut numbers in hospital by about half. Claudia Hammond discusses the ethics of who should be given it. And a new exhibition on outwitting cancer.

Trials stopped early of a new Covid antiviral pill, Molnupiravir, as it may cut numbers of people in hospital by about a half. Claudia Hammond discusses the ethical questions of who should be given it. Plus Unicef report on findings about childhood mental health before and during the pandemic. And a new exhibition on the researchers and trial participants outwitting cancer.

Presenter: Claudia Hammond
Producer: Erika Wright

(Photo: An experimental Covid-19 treatment pill called Molnupiravir. Photo credit: Merck/Reuters)

Available now

29 minutes

Last on

Sun 10 Oct 202101:32GMT

Broadcasts

  • Wed 6 Oct 202119:32GMT
  • Thu 7 Oct 202103:32GMT
  • Thu 7 Oct 202104:32GMT
  • Thu 7 Oct 202108:32GMT
  • Thu 7 Oct 202112:32GMT
  • Sat 9 Oct 202101:32GMT
  • Sun 10 Oct 202101:32GMT

Podcast